vs
ChargePoint Holdings, Inc.(CHPT)与PUMA BIOTECHNOLOGY, INC.(PBYI)财务数据对比。点击上方公司名可切换其他公司
ChargePoint Holdings, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.4倍($105.7M vs $75.5M),PUMA BIOTECHNOLOGY, INC.同比增速更快(27.7% vs 6.1%),PUMA BIOTECHNOLOGY, INC.自由现金流更多($14.4M vs $-23.6M),过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高(31.3% vs -4.5%)
ChargePoint Holdings, Inc.是总部位于美国加利福尼亚州坎贝尔的电动汽车基础设施企业,运营着全球规模最大的独立所有电动汽车充电桩在线网络,站点覆盖14个国家,同时也自主研发生产相关充电技术设备。
彪马生物技术是一家公开上市的生物制药企业,总部位于美国加利福尼亚州洛杉矶,专注于创新药物研发相关业务,在生物制药领域开展研发与商业化运营。
CHPT vs PBYI — 直观对比
营收规模更大
CHPT
是对方的1.4倍
$75.5M
营收增速更快
PBYI
高出21.6%
6.1%
自由现金流更多
PBYI
多$37.9M
$-23.6M
两年增速更快
PBYI
近两年复合增速
-4.5%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $105.7M | $75.5M |
| 净利润 | $-52.5M | — |
| 毛利率 | 30.7% | 69.3% |
| 营业利润率 | -42.0% | 22.7% |
| 净利率 | -49.7% | — |
| 营收同比 | 6.1% | 27.7% |
| 净利润同比 | 32.4% | — |
| 每股收益(稀释后) | $-2.23 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CHPT
PBYI
| Q4 25 | $105.7M | $75.5M | ||
| Q3 25 | $98.6M | $54.5M | ||
| Q2 25 | $97.6M | $52.4M | ||
| Q1 25 | $101.9M | $46.0M | ||
| Q4 24 | $99.6M | $59.1M | ||
| Q3 24 | $108.5M | $80.5M | ||
| Q2 24 | $107.0M | $47.1M | ||
| Q1 24 | $115.8M | $43.8M |
净利润
CHPT
PBYI
| Q4 25 | $-52.5M | — | ||
| Q3 25 | $-66.2M | $8.8M | ||
| Q2 25 | $-57.1M | $5.9M | ||
| Q1 25 | $-58.8M | $3.0M | ||
| Q4 24 | $-77.6M | — | ||
| Q3 24 | $-68.9M | $20.3M | ||
| Q2 24 | $-71.8M | $-4.5M | ||
| Q1 24 | $-94.7M | $-4.8M |
毛利率
CHPT
PBYI
| Q4 25 | 30.7% | 69.3% | ||
| Q3 25 | 31.2% | 77.7% | ||
| Q2 25 | 28.7% | 76.5% | ||
| Q1 25 | 28.2% | 77.1% | ||
| Q4 24 | 22.9% | 76.4% | ||
| Q3 24 | 23.6% | 63.9% | ||
| Q2 24 | 22.1% | 77.4% | ||
| Q1 24 | 19.3% | 75.5% |
营业利润率
CHPT
PBYI
| Q4 25 | -42.0% | 22.7% | ||
| Q3 25 | -59.8% | 17.6% | ||
| Q2 25 | -55.1% | 12.7% | ||
| Q1 25 | -53.9% | 8.7% | ||
| Q4 24 | -68.4% | 22.6% | ||
| Q3 24 | -57.8% | 27.4% | ||
| Q2 24 | -62.7% | -4.6% | ||
| Q1 24 | -80.2% | -5.3% |
净利率
CHPT
PBYI
| Q4 25 | -49.7% | — | ||
| Q3 25 | -67.1% | 16.2% | ||
| Q2 25 | -58.5% | 11.2% | ||
| Q1 25 | -57.7% | 6.5% | ||
| Q4 24 | -77.9% | — | ||
| Q3 24 | -63.5% | 25.2% | ||
| Q2 24 | -67.1% | -9.6% | ||
| Q1 24 | -81.8% | -11.0% |
每股收益(稀释后)
CHPT
PBYI
| Q4 25 | $-2.23 | $0.26 | ||
| Q3 25 | $-2.85 | $0.17 | ||
| Q2 25 | $-0.12 | $0.12 | ||
| Q1 25 | $-5.83 | $0.06 | ||
| Q4 24 | $-3.56 | $0.40 | ||
| Q3 24 | $-3.22 | $0.41 | ||
| Q2 24 | $-0.17 | $-0.09 | ||
| Q1 24 | $-23.36 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $180.5M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $38.4M | $130.3M |
| 总资产 | $848.0M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势,按日历期对齐
现金及短期投资
CHPT
PBYI
| Q4 25 | $180.5M | $97.5M | ||
| Q3 25 | $194.1M | $94.4M | ||
| Q2 25 | $195.9M | $96.0M | ||
| Q1 25 | $224.6M | $93.2M | ||
| Q4 24 | $219.4M | $101.0M | ||
| Q3 24 | $243.3M | $96.7M | ||
| Q2 24 | $261.9M | $96.8M | ||
| Q1 24 | $327.4M | $107.2M |
总债务
CHPT
PBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益
CHPT
PBYI
| Q4 25 | $38.4M | $130.3M | ||
| Q3 25 | $70.7M | $115.3M | ||
| Q2 25 | $118.6M | $104.7M | ||
| Q1 25 | $137.5M | $97.1M | ||
| Q4 24 | $181.0M | $92.1M | ||
| Q3 24 | $230.9M | $71.1M | ||
| Q2 24 | $277.9M | $48.5M | ||
| Q1 24 | $327.7M | $51.0M |
总资产
CHPT
PBYI
| Q4 25 | $848.0M | $216.3M | ||
| Q3 25 | $870.3M | $202.9M | ||
| Q2 25 | $897.6M | $194.9M | ||
| Q1 25 | $898.2M | $196.2M | ||
| Q4 24 | $966.3M | $213.3M | ||
| Q3 24 | $1.0B | $220.7M | ||
| Q2 24 | $1.1B | $205.0M | ||
| Q1 24 | $1.1B | $214.1M |
负债/权益比
CHPT
PBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-22.5M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-23.6M | $14.4M |
| 自由现金流率自由现金流/营收 | -22.3% | 19.1% |
| 资本支出强度资本支出/营收 | 1.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-69.6M | $41.7M |
8季度趋势,按日历期对齐
经营现金流
CHPT
PBYI
| Q4 25 | $-22.5M | $14.4M | ||
| Q3 25 | $-6.2M | $9.7M | ||
| Q2 25 | $-33.0M | $14.1M | ||
| Q1 25 | $-2.7M | $3.6M | ||
| Q4 24 | $-30.6M | $15.6M | ||
| Q3 24 | $-51.2M | $11.0M | ||
| Q2 24 | $-62.5M | $1.0M | ||
| Q1 24 | $-41.5M | $11.2M |
自由现金流
CHPT
PBYI
| Q4 25 | $-23.6M | $14.4M | ||
| Q3 25 | $-7.5M | $9.7M | ||
| Q2 25 | $-34.0M | $14.1M | ||
| Q1 25 | $-4.6M | $3.6M | ||
| Q4 24 | $-33.4M | $15.6M | ||
| Q3 24 | $-55.0M | $11.0M | ||
| Q2 24 | $-66.0M | $1.0M | ||
| Q1 24 | $-46.2M | — |
自由现金流率
CHPT
PBYI
| Q4 25 | -22.3% | 19.1% | ||
| Q3 25 | -7.6% | 17.7% | ||
| Q2 25 | -34.9% | 26.8% | ||
| Q1 25 | -4.5% | 7.7% | ||
| Q4 24 | -33.5% | 26.4% | ||
| Q3 24 | -50.7% | 13.7% | ||
| Q2 24 | -61.7% | 2.1% | ||
| Q1 24 | -39.9% | — |
资本支出强度
CHPT
PBYI
| Q4 25 | 1.0% | 0.0% | ||
| Q3 25 | 1.3% | 0.0% | ||
| Q2 25 | 1.1% | 0.0% | ||
| Q1 25 | 1.9% | 0.1% | ||
| Q4 24 | 2.8% | 0.0% | ||
| Q3 24 | 3.5% | 0.0% | ||
| Q2 24 | 3.2% | 0.0% | ||
| Q1 24 | 4.1% | 0.0% |
现金转化率
CHPT
PBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CHPT
| Products | $56.4M | 53% |
| License And Service | $42.0M | 40% |
| Other | $7.3M | 7% |
PBYI
暂无分部数据